Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

  1. Yang, J.C.H.
  2. Brose, M.S.
  3. Castro, G.
  4. Kim, E.S.
  5. Lassen, U.N.
  6. Leyvraz, S.
  7. Pappo, A.
  8. López-Ríos, F.
  9. Reeves, J.A.
  10. Fellous, M.
  11. Penault-Llorca, F.
  12. Rudzinski, E.R.
  13. Tabatabai, G.
  14. Vassal, G.
  15. Drilon, A.
  16. Trent, J.
Journal:
BMC Cancer

ISSN: 1471-2407

Year of publication: 2022

Volume: 22

Issue: 1

Type: Article

DOI: 10.1186/S12885-022-09687-X GOOGLE SCHOLAR lock_openOpen access editor